Hepatoblastomas (HBs) and pediatric hepatocellular carcinomas (HCCs) together account
for almost 80% of primary malignant liver tumors in children and adolescents/young adults …

Pediatric hepatocellular carcinoma (HCC) is the second common malignant liver tumor in
children after hepatoblastoma. It differs from the adult HCC in the etiological predisposition …

This guidance provides a data-supported approach to the diagnosis, staging, and treatment
of patients diagnosed with hepatocellular carcinoma (HCC). A guidance document is …

Liver tumors in childhood are rare. Approximately two-thirds of all pediatric liver tumors are
malignant, including hepatoblastoma (HB; 37%), hepatocellular carcinoma (HCC; 21%), and …

Fibrolamellar carcinoma (FLC) is a rare malignant entity arising from the liver and primarily
affecting patients in late adolescence and young adulthood. FLC tumors are characterized …

The liver is the third most common site of abdominal tumors in children. This review article
aims to summarize current evidence surrounding identification and diagnosis of primary …

Objective To evaluate outcomes and predictors of survival of pediatric thyroid carcinoma,
specifically papillary thyroid carcinoma. Methods SEER was searched for surgical pediatric …

Liver tumors are relatively rare in childhood, but may be associated with a range of
diagnostic, genetic, therapeutic, and surgical challenges sufficient to tax even the most …

Malignant hepatic tumors in children are rare, comprising 1.3% of all pediatric malignancies.
Following hepatoblastoma, hepatocellular carcinoma is the second most common. Other …

Introduction. Hepatocellular carcinoma (HCC) is a rare pediatric cancer accounting for 0.5%
of all pediatric malignancies. This study examines a large cohort of HCC patients in an effort …